文献速递腹部技术与安全US

对比增强超声肝脏影像报告和数据系统(LI-RADS)对肝细胞癌的风险分层及LR-5与LR-M诊断性能的系统评价和荟萃分析

Risk stratification for hepatocellular carcinoma of contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis.
PubMed 文献 · Clin Radiol · 2022-02-12

该系统评价与荟萃分析纳入10项研究共5,543例患者6,124个病灶(含4,492个肝细胞癌),评估对比增强超声LI-RADS各分类中肝细胞癌及总体恶性肿瘤的比例,以及LR-5诊断肝细胞癌、LR-M诊断非肝细胞癌恶性肿瘤的效能。结果显示肝细胞癌风险自LR-1至LR-5逐渐升高,LR-5中肝细胞癌比例为97%,LR-M中为44%;LR-5诊断肝细胞癌特异度为0.95,LR-M诊断非肝细胞癌恶性肿瘤的SROC曲线下面积为0.89。

要点

  • LR-1中无肝细胞癌,LR-2至LR-5肝细胞癌比例随分类升高而增加,LR-5中肝细胞癌比例为97%。
  • LR-M中肝细胞癌比例为44%,LR-M诊断非肝细胞癌恶性肿瘤敏感度0.81、特异度0.92、准确率0.91。
  • LR-5诊断肝细胞癌敏感度0.76、特异度0.95、准确率0.82,SROC曲线下面积0.83。

核心结论

  • 肝细胞癌风险自LR-1至LR-5逐渐升高,LR-1中无肝细胞癌,LR-3中肝细胞癌比例为22%,低于早期研究报告;LR-5中肝细胞癌比例为97%,LR-M中为44%;LR-5诊断肝细胞癌特异度高达95%。

研究设计与样本

  • 系统评价与荟萃分析,检索PubMed、Embase和Cochrane Central数据库2016年至2021年2月关于CEUS LI-RADS v2016和v2017的研究,最终纳入10项研究,共5,543例患者6,124个病灶,其中4,492个肝细胞癌,采用随机效应模型分析。

诊断标准与关键数值

  • LR-5诊断肝细胞癌的敏感度0.76、特异度0.95、准确率0.82,SROC曲线下面积0.83;LR-M诊断非肝细胞癌恶性肿瘤的敏感度0.81、特异度0.92、准确率0.91,SROC曲线下面积0.89。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To evaluate the risk stratification of hepatocellular carcinoma (HCC) and overall malignancies in different contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System (LI-RADS) categories, and to explore the diagnostic performance of LR-5 for HCC and LR-M for non-HCC malignancies.

MATERIALS AND METHODS: The PubMed, Embase, and Cochrane Central databases were searched from 2016 to February 2021 for studies on CEUS LI-RADS v2016 and v2017. The proportion of HCC and overall malignancy in each LI-RADS category and the sensitivity, specificity, accuracy, diagnostic odds ratio (DOR) and area under the receiver operating characteristic curve (AUC) of LR-5 and LR-M categories were determined using a random effects model.

RESULTS: A total of 113 studies were retrieved and 10 studies were included. A total of 5,543 patients with 6,124 lesions were included, including 4,492 HCC. There was no HCC in LR-1, and the proportion of HCC in LR-2-5 increased with the increase of category. The proportion of HCC in LR-5 was 97%, and that in LR-M was 44%. The sensitivity, specificity, and accuracy of CEUS LR-5 for HCC were 0.76, 0.95, and 0.82, respectively, and the area under the SROC curve was 0.83. The sensitivity, specificity, and accuracy of CEUS LR-M for non-HCC malignancies were 0.81, 0.92, and 0.91, and the area under the SROC curve was 0.89.

CONCLUSION: The risk of HCC increases gradually from LR-1 to LR-5, in which there was no HCC lesion in LR-1 and the proportion of HCC in LR-3 was 22%, lower than that reported in earlier studies. The proportion of HCC in LR-5 was 97% and that in LR-M was 44%. LR-5 has a high specificity of 95% for the diagnosis of HCC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Qin, Zhou, Ding, et al. Risk stratification for hepatocellular carcinoma of contrast-enhanced ultrasound Liver Imaging Reporting and Data System (LI-RADS) and the diagnostic performance of LR-5 and LR-M: a systematic review and meta-analysis. Clin Radiol. 2022. PMID: 35164930. doi:10.1016/j.crad.2022.01.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。